Top

Current Gastroenterology Reports

Published in:

01-09-2019 | Crohn's Disease | Nutrition and Obesity (S McClave, Section Editor)

Classifying Enteral Nutrition: Tailored for Clinical Practice

Authors: Berkeley N. Limketkai, Neha D. Shah, Ghias N. Sheikh, Karen Allen

Published in: Current Gastroenterology Reports | Issue 9/2019

Abstract

Purpose of Review

To discuss the different forms of enteral nutrition, while outlining available evidence for its use in specific conditions and how enteral nutrition composition may or may not influence relevant outcomes.

Recent Findings

Enteral nutrition formulas were originally conceived as a liquid form of nutrition for individuals who otherwise could not consume adequate calories through solid food. Over time, the emergence of specialty formulas marketed to benefit specific diseases or conditions has led to a broad range of potentially confusing options. While most options have theoretical benefit for their marketed conditions, the evidence demonstrating practical benefit is not consistent.

Summary

Overall, the certainty of evidence for specialty formulas remains low or very low. In most instances, one could begin with standard polymeric formula, except in cases where disease-specific formulas are recommended. Much research is nonetheless still needed to clarify whether some disease-specific formulas are truly beneficial or merely theoretical features.

Lochs H, Allison SP, Meier R, Pirlich M, Kondrup J, Schneider S, et al. Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics. Clin Nutr. 2006;25(2):180–6. https://doi.org/10.1016/j.clnu.2006.02.007.CrossRefPubMed

Forbes A, Escher J, Hebuterne X, Klek S, Krznaric Z, Schneider S, et al. ESPEN guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017;36(2):321–47. https://doi.org/10.1016/j.clnu.2016.12.027.CrossRefPubMed

•• Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2018;4:CD000542. https://doi.org/10.1002/14651858.CD000542.pub3 Systematic review and meta-analysis demonstring the efficacy of exclusive enteral nutrition for Crohn's disease. CrossRefPubMed

Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s disease. Inflamm Bowel Dis. 2014;20(8):1353–60. https://doi.org/10.1097/MIB.0000000000000110.CrossRefPubMed

Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut. 2006;55(3):356–61. https://doi.org/10.1136/gut.2004.062554.CrossRefPubMedPubMedCentral

Ricour C, Duhamel JF, Nihoul-Fekete C. Use of parenteral and elementary enteral nutrition in the treatment of Crohn’s disease and ulcerative colitis in children. Arch Fr Pediatr. 1977;34(6):505–13.PubMed

Yang G, Wu XT, Zhou Y, Wang YL. Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials. World J Gastroenterol. 2005;11(25):3935–8.CrossRefPubMedPubMedCentral

Kamarul Zaman M, Chin KF, Rai V, Majid HA. Fiber and prebiotic supplementation in enteral nutrition: a systematic review and meta-analysis. World J Gastroenterol. 2015;21(17):5372–81. https://doi.org/10.3748/wjg.v21.i17.5372.CrossRefPubMedPubMedCentral

Halmos EP. Role of FODMAP content in enteral nutrition-associated diarrhea. J Gastroenterol Hepatol. 2013;28(Suppl 4):25–8. https://doi.org/10.1111/jgh.12272.CrossRefPubMed

10.

• Schumann D, Klose P, Lauche R, Dobos G, Langhorst J, Cramer H. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Nutrition. 2018;45:24–31. https://doi.org/10.1016/j.nut.2017.07.004 Systematic review and meta-analysis of the benefit of the low FODMAP diet for symptoms of irritable bowel syndrome. CrossRefPubMed

11.

Yoon SR, Lee JH, Lee JH, Na GY, Lee KH, Lee YB, et al. Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial. Nutr J. 2015;14:116. https://doi.org/10.1186/s12937-015-0106-0.CrossRefPubMedPubMedCentral

12.

McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a high jejunostomy do not need a special diet. Gastroenterology. 1986;91(1):25–33.CrossRefPubMed

13.

Levy E, Frileux P, Sandrucci S, Ollivier JM, Masini JP, Cosnes J, et al. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg. 1988;75(6):549–53.CrossRefPubMed

14.

Joly F, Dray X, Corcos O, Barbot L, Kapel N, Messing B. Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology. 2009;136(3):824–31. https://doi.org/10.1053/j.gastro.2008.10.084.CrossRefPubMed

15.

Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247–307. https://doi.org/10.1016/j.clnu.2016.01.020.CrossRefPubMed

16.

Huang XX, Wang XP, Ma JJ, Jing DD, Wang PW, Wu K. Effects of enteral nutrition supplemented with glutamine and arginine on gut barrier in patients with severe acute pancreatitis: a prospective randomized controlled trial. Zhonghua Yi Xue Za Zhi. 2008;88(34):2407–9.PubMed

17.

Lasztity N, Hamvas J, Biro L, Nemeth E, Marosvolgyi T, Decsi T, et al. Effect of enterally administered n-3 polyunsaturated fatty acids in acute pancreatitis--a prospective randomized clinical trial. Clin Nutr. 2005;24(2):198–205. https://doi.org/10.1016/j.clnu.2004.12.008.CrossRefPubMed

18.

Petrov MS, Atduev VA, Zagainov VE. Advanced enteral therapy in acute pancreatitis: is there a room for immunonutrition? A meta-analysis. Int J Surg. 2008;6(2):119–24. https://doi.org/10.1016/j.ijsu.2008.01.003.CrossRefPubMed

19.

Asrani V, Chang WK, Dong Z, Hardy G, Windsor JA, Petrov MS. Glutamine supplementation in acute pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology. 2013;13(5):468–74. https://doi.org/10.1016/j.pan.2013.07.282.CrossRefPubMed

20.

Martin IC, Marinho LH, Brown AE, McRobbie D. Medium chain triglycerides in the management of chylous fistulae following neck dissection. Br J Oral Maxillofac Surg. 1993;31(4):236–8.CrossRefPubMed

21.

Abu Hilal M, Layfield DM, Di Fabio F, Arregui-Fresneda I, Panagiotopoulou IG, Armstrong TH, et al. Postoperative chyle leak after major pancreatic resections in patients who receive enteral feed: risk factors and management options. World J Surg. 2013;37(12):2918–26. https://doi.org/10.1007/s00268-013-2171-x.CrossRefPubMed

22.

Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006;25(2):285–94. https://doi.org/10.1016/j.clnu.2006.01.018.CrossRefPubMed

23.

Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A, et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology. 1984;4(2):279–87.CrossRefPubMed

24.

Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, et al. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:CD001939. https://doi.org/10.1002/14651858.CD001939.pub4.CrossRefPubMed

25.

• McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159–211. https://doi.org/10.1177/0148607115621863 Guidelines for the use of enteral nutrition in critical illness. CrossRefPubMed

26.

Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005;28(9):2267–79.CrossRefPubMed

27.

Lansink M, Hofman Z, Genovese S, Rouws C, Ceriello A. Improved glucose profile in patients with type 2 diabetes with a new, high-protein, diabetes-specific tube feed during 4 hours of continuous feeding. JPEN J Parenter Enteral Nutr. 2017;41(6):968–75. https://doi.org/10.1177/0148607115625635.CrossRefPubMed

28.

Alish CJ, Garvey WT, Maki KC, Sacks GS, Hustead DS, Hegazi RA, et al. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther. 2010;12(6):419–25. https://doi.org/10.1089/dia.2009.0185.CrossRefPubMed

29.

Ceriello A, Lansink M, Rouws CH, van Laere KM, Frost GS. Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. Diabetes Res Clin Pract. 2009;84(3):259–66. https://doi.org/10.1016/j.diabres.2009.02.013.CrossRefPubMed

30.

Pohl M, Mayr P, Mertl-Roetzer M, Lauster F, Haslbeck M, Hipper B, et al. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial. JPEN J Parenter Enteral Nutr. 2009;33(1):37–49. https://doi.org/10.1177/0148607108324582.CrossRefPubMed

31.

McMahon MM, Nystrom E, Braunschweig C, Miles J, Compher C, American Society for P, et al. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013;37(1):23–36. https://doi.org/10.1177/0148607112452001. CrossRefPubMed

32.

Choban P, Dickerson R, Malone A, Worthington P, Compher C, American Society for P, et al. A.S.P.E.N. clinical guidelines: nutrition support of hospitalized adult patients with obesity. JPEN J Parenter Enteral Nutr. 2013;37(6):714–44. https://doi.org/10.1177/0148607113499374.CrossRefPubMed

33.

Stratton RJ, Bircher G, Fouque D, Stenvinkel P, de Mutsert R, Engfer M, et al. Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2005;46(3):387–405. https://doi.org/10.1053/j.ajkd.2005.04.036.CrossRefPubMed

34.

Cano N, Fiaccadori E, Tesinsky P, Toigo G, Druml W, Dgem, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006;25(2):295–310. https://doi.org/10.1016/j.clnu.2006.01.023. CrossRefPubMed

35.

al-Saady NM, Blackmore CM, Bennett ED. High fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med. 1989;15(5):290–5.CrossRefPubMed

36.

Mesejo A, Acosta JA, Ortega C, Vila J, Fernandez M, Ferreres J, et al. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients. Clin Nutr. 2003;22(3):295–305.CrossRefPubMed

37.

van den Berg B, Bogaard JM, Hop WC. High fat, low carbohydrate, enteral feeding in patients weaning from the ventilator. Intensive Care Med. 1994;20(7):470–5.CrossRefPubMed

38.

National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564–75. https://doi.org/10.1056/NEJMoa062200.CrossRef

39.

National Heart L, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials N, Rice TW, Wheeler AP, Thompson BT, Steingrub J, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012;307(8):795–803. https://doi.org/10.1001/jama.2012.137.CrossRef

40.

Needham DM, Dinglas VD, Morris PE, Jackson JC, Hough CL, Mendez-Tellez PA, et al. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med. 2013;188(5):567–76. https://doi.org/10.1164/rccm.201304-0651OC.CrossRefPubMedPubMedCentral

41.

Arabi YM, Aldawood AS, Haddad SH, Al-Dorzi HM, Tamim HM, Jones G, et al. Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med. 2015;372(25):2398–408. https://doi.org/10.1056/NEJMoa1502826. CrossRefPubMed

42.

Arabi YM, Aldawood AS, Al-Dorzi HM, Tamim HM, Haddad SH, Jones G, et al. Permissive underfeeding or standard enteral feeding in high- and low-nutritional-risk critically ill adults. Post hoc analysis of the PermiT Trial. Am J Respir Crit Care Med. 2017;195(5):652–62. https://doi.org/10.1164/rccm.201605-1012OC.CrossRefPubMed

43.

• Compher C, Chittams J, Sammarco T, Nicolo M, Heyland DK. Greater protein and energy intake may be associated with improved mortality in higher risk critically ill patients: a multicenter, multinational observational study. Crit Care Med. 2017;45(2):156–63. https://doi.org/10.1097/CCM.0000000000002083 Study demonstrating the importance of protein in critically ill patients. CrossRefPubMed

44.

Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group Crit Care Med. 1999;27(8):1409–20.

45.

Rice TW, Wheeler AP, Thompson BT, deBoisblanc BP, Steingrub J, Rock P, et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA. 2011;306(14):1574–81. https://doi.org/10.1001/jama.2011.1435.CrossRefPubMedPubMedCentral

46.

Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34(4):1033–8. https://doi.org/10.1097/01.CCM.0000206111.23629.0A.CrossRefPubMed

47.

Nicolo M, Heyland DK, Chittams J, Sammarco T, Compher C. Clinical outcomes related to protein delivery in a critically ill population: a multicenter, multinational observation study. JPEN J Parenter Enteral Nutr. 2016;40(1):45–51. https://doi.org/10.1177/0148607115583675.CrossRefPubMed

48.

• Reignier J, Boisrame-Helms J, Brisard L, Lascarrou JB, Ait Hssain A, Anguel N, et al. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet. 2018;391(10116):133–43. https://doi.org/10.1016/S0140-6736(17)32146-3 Study evaluating enteral versus parenteral nutrition in critically ill patients. CrossRefPubMed

Title: Classifying Enteral Nutrition: Tailored for Clinical Practice
Authors: Berkeley N. Limketkai
Neha D. Shah
Ghias N. Sheikh
Karen Allen
Publication date: 01-09-2019
Publisher: Springer US
Keywords: Crohn's Disease
Nutrition
Published in: Current Gastroenterology Reports / Issue 9/2019
Print ISSN: 1522-8037
Electronic ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-019-0708-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Classifying Enteral Nutrition: Tailored for Clinical Practice

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 9/2019

Novel Screening Tests for Barrett’s Esophagus

Diverticular Disease in the Elderly

Treatment of Pruritus Secondary to Liver Disease

Salvage Options for Fundoplication Failure

Liver Disease in Pregnancy and Transplant

Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page